What I measure → Imaging & Body Comp

What's actually going on inside me

Blood tests and clocks are indirect. Imaging is a direct look — at my arteries, liver, brain, and body composition. Here's what the scans show: the genuine wins, and the things I'm actively working on. No cherry-picking.

Heart & arteries

My coronary scans — the good and the work-in-progress

The work-in-progress half

A little plaque — caught early

Yes, I have a small, early amount of plaque ("mild") plus a little calcium. Real, but not alarming — and exactly why I started a low-dose statin and push ApoB down hard.

Cleerly: total plaque 100 mm³, Stage 1, 75% non-calcified, max stenosis 14–15% · CAC (Agatston) 37 (mild), ~19%/yr
The reassuring half

…but none of the dangerous kind

No contradiction — these are two readings from the same scan. Plaque comes in two flavors: stable, and the soft, rupture-prone "vulnerable" type that actually causes heart attacks. Of all the plaque I have, the vulnerable kind measures zero. That's the best possible result.

Cleerly CCTA · low-density (vulnerable) plaque = 0 mm³ (2024-08)
Lever identified

Pericardial fat — a target

Fat around the heart runs higher than I want. The fix is the same one that helps my muscle and lipids: resistance training + lowering ApoB.

pericardial fat volume 151.7 mL (youthful target <100) · CT 2026-01
Honest framing

Why I show the plaque

Plenty of people my age would hide a CAC score. I don't — the zero-vulnerable-plaque result only means something because I show the whole picture.

Liver & body composition

Where genetics lost — and where I'm rebuilding

Genes aren't destiny

Zero liver fat (just a touch enlarged)

I carry a gene linked to fatty liver — yet my MRI shows no liver fat (grade 0), proof that lifestyle can beat the gene. It does read slightly enlarged, but that's benign — think of it like a muscle that's a bit bigger because it's been worked, not a sign of disease.

MRI PDFF liver-fat 4.8% → grade 0 (no steatosis) despite PNPLA3 rs738409 G/G · liver mildly enlarged (benign) · 2026-01
Rebuilding

Muscle I lost to a shoulder injury — coming back

My lean mass dipped across recent scans — but this is not age-related wasting. It followed a shoulder injury and surgery that sidelined training on that side. Western medicine's verdict was that I need a Total Shoulder Replacement — the cartilage there has degenerated to bone-on-bone. I declined. Instead I had the bone spurs arthroscopically removed (that's the surgery, plus rehab), and I'm pursuing regenerative-medicine therapies to rebuild the joint rather than replace it. I'm in physical therapy now and steadily rebuilding the muscle.

ALMI 8.6 → 8.4 → 8.1 kg/m² · post shoulder-surgery deconditioning (not sarcopenia) · declined total shoulder replacement (bone-on-bone) → arthroscopic spur removal + regenerative therapy · PT in progress · DXA
Whole-body & brain

The big-picture scans

Screening

Full-body MRI — two scans, cross-checked

I've now had two whole-body MRIs — a Prenuvo (US, 2024) and a Vital full-body (India, 2026). The headline from both: no tumors, no cancer. Here's everything they found — and where the two scans agree (🤝) or disagree (⚖️):

  • ✅ No malignancy on either scan — the result that matters most
  • 🤝 Right shoulder — bone spurs + a torn labrum (2024: paralabral cyst; 2026: a 5.6 cm subcoracoid bursal cyst) — both scans confirm real pathology; since repaired with stem cells & exosomes — the reason for the muscle rebuild above
  • 🤝 Spine — cervical & lumbar degenerative disc disease on both scans; the 2026 MRI adds detail: an L4–L5 annular tear with nerve-root compression and a severely collapsed L5–S1 disc, plus C3–C7 bulges
  • 🤝 Left mastoid — a little fluid behind the ear on both scans (2024 & 2026), so it's persistent; possibly travel/congestion-related (a long international flight preceded the 2026 scan) — my next retest should clarify
  • ⚖️ Liver — Prenuvo read it slightly enlarged (benign — like a well-worked muscle); the 2026 scan read it normal in size. Either way, what actually matters — liver fat — is just 4.8% (normal), despite my 3× genetic NAFLD risk
  • ⚖️ Prostate — Prenuvo: slightly enlarged (BPH); 2026: normal — my PSA & free-PSA stay reassuring either way
  • Thyroid — Prenuvo noted it small (diminutive) — fits my hypothyroidism / prior thyroiditis
  • Brain — the 2026 read noted mild age-related changes but normal hippocampi — consistent with my brain-age work
  • Also: a minimal deviated nasal septum · a detached rib
Prenuvo whole-body MRI 2024-09 + Vital full-body MRI (India) 2026-01 · 🤝 corroborated: L-mastoid fluid, cervical/lumbar disc disease, R-shoulder cyst · ⚖️ disagree: liver & prostate size (Prenuvo enlarged → 2026 normal) · liver PDFF 4.8% grade 0 (AIWO 2026-01)
Baseline set

Brain & bone

A volumetric brain MRI puts my brain age at 61 — two years younger than my 63 — with a region-by-region breakdown I track against the early p-Tau signal on my Genomics page. My DEXA tracks bone density alongside body composition.

  • Brain age 61 — −2 yr vs my chronological 63 (AIWO MRI, Jan 2026); TruDiagnostic Symphony agrees at 63.5
  • Region by region — my strengths & focus areas — in plain terms, my best-preserved regions are the caudate, occipital & frontal; my focus areas (the ones the scan flags to work on) are the parietal, hippocampus & thalamus. For clinicians: age-matched percentiles caudate 85 · occipital 70 · frontal 59 · temporal 54 · hippocampus 33 · parietal 29 (50th = average; higher = more preserved). I track the hippocampus yearly given my p-Tau signal.
  • DEXA (2020 → 2026) — bone density normal (T-score normal; Z-score +1.4 — denser than my age group). Body fat read 10% (2020, Michigan DexaFit) and 19.2% (2026, India) — but those are different machines & reference populations (the India scan may use Indian-population ranges), so that jump isn't strictly apples-to-apples; my Michigan series is the consistent baseline. Visceral fat stays low either way.
AIWO whole-body MRI 2026-01-07 · BrainAge 61 (−2y) · BrainKey per-region volumetrics (hippocampus 33rd pct, caudate 85th) · DEXA: Michigan DexaFit series vs India FUJIFILM 2026 (different machine/reference population — not directly comparable) · T-score normal / Z +1.4 · body fat 10% (MI) vs 19.2% (IN) · ALMI 8.1 · VAT low
Data freshness: imaging spans 2024–2026 (each scan dated above). Imaging is periodic by nature — I update each as new scans come in.
Educational n-of-1 documentation — not medical advice. All findings are from my own imaging, dated individually. © Dave Pascoe